Skip to main content

Table 2 Comparison of the therapeutic outcomes between groups

From: Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

 

rATG n = 41

IL2-RA n = 147

P-value

Clinically-suspected acute rejection, % (n/n)

9.8 (4/41)

8.8 (13/147)

0.832

Graft lost because of rejection, n/na

0/4

4/13

Biopsy-proven acute rejection, n/N

1/9

6/12

0.01

Dn-DSA

2 (4.9)

8 (5.4)

0.44

  1. Dn-DSA = de novo donor-specific antigen; IL2-RA = IL-2 receptor antagonist; rATG = rabbit antithymocyte globulin
  2. aDenominator is the number of patients with acute rejection